Letter to the editor submitted in response to ‘Should the presence of psoriatic arthritis change how we manage psoriasis?’

Matteo Megnaa Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico IICorrespondence[email protected]

https://orcid.org/0000-0003-1803-2046

Sonia Sofia Ocampo-Garzaa Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II;b Dermatology Department, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico

Gabriella Fabbrocinia Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II

Luca Potestioa Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II

References

Chan WH, Singh R, Feldman SR. Should the presence of psoriatic arthritis change how we manage psoriasis? J Dermatolog Treat. 2021;32(8):863–865.
PubMed Web of Science ®Google Scholar
Santos G, Sousa LE, João AMBL. Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab—a paradoxical effect? A case report. An Bras Dermatol. 2013;88(6 suppl 1):26–28.
PubMed Web of Science ®Google Scholar
Megna M, Ocampo-Garza SS, Potestio L, et al. New-onset psoriatic arthritis under biologics in psoriasis patients: an increasing challenge? Biomedicines. 2021;9(10):1482.
PubMed Web of Science ®Google Scholar
Napolitano M, Balato N, Caso F, et al. Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. Clin Exp Rheumatol. 2017;35(1):137–140.
PubMed Web of Science ®Google Scholar
Gisondi P, Bellinato F, Targher G, et al. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis. Ann. Rheum. Dis. 2021.
PubMedGoogle Scholar
Wang Y, Zhang L, Yang M, et al. Development of a predictive model for screening patients with psoriasis at increased risk of psoriatic arthritis. Dermatol Ther. 2021. doi:10.1007/s13555-021-00663-0.
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter to the editor submitted in response to ‘Should the presence of psoriatic arthritis change how we manage psoriasis?’

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter to the editor submitted in response to ‘Should the presence of psoriatic arthritis change how we manage psoriasis?’

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date